Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment

Most drugs used for the treatment of solid tumors can induce hepatitis B reactivation in HBs antigen-positive patients. The risk is well documented for conventional chemotherapy agents, everolimus and imatinib. HBV screening can be recommended before systemic treatment initiation. In patients with positive HBs antigen, preemptive treatment should be given, using lamivudine.

from Cancer via ola Kala on Inoreader http://ift.tt/2fbgsL4
via IFTTT